血红氧酶-1调节CD62E依赖的内皮细胞-单细胞相互作用,并减轻小鼠中的HLA-I诱导的移植血管病变
Laura Schuster1,2, Marcin Zaradzki3, Henrike Janssen1
1Department of Anesthesiology, Heidelberg University Hospital, Heidelberg, Germany.
Frontiers in immunology
|March 24, 2025
概括
通过激活内皮细胞,捐赠体特异性抗体会导致移植血管病变. 血氧酶-1 (HO-1) 调节和抗CD62E抗体在预防这种排斥和保持器官功能方面显示出有前途.
科学领域:
- 免疫学 免疫学 免疫学
- 移植生物学 移植生物学
- 血管生物学 血管生物学
背景情况:
- 移植血管病变 (TV) 是固体器官移植失败的主要原因.
- 与内皮细胞 (ECs) 结合的捐赠者特异性抗体 (DSAs) 是TV的主要危险因素.
- 白细胞的招募和光滑肌肉细胞的增殖导致亲密增生,特征TV.
研究的目的:
- 研究抗HLA-I抗体在EC激活和白细胞招募中的作用.
- 评估血氧酶-1 (HO-1) 调制和抗CD62E抗体在预防TV的治疗潜力.
主要方法:
- 在体外研究涉及化大动脉ECs与抗HLA-I抗体.
- 在EC单层中对单细胞粘附和转移的评估.
- 在体内研究使用小鼠异型大动脉移植模型.
- 药物诱导HO-1和使用抗CD62E抗体.
主要成果:
- 抗HLA-I抗体以CD62E依赖的方式增加单细胞粘附和传播.
- 在小鼠模型中,HO-1调制改善了抗MHC I抗体诱导的TV.
- 反CD62E抗体治疗减缓了TV的发育速度.
结论:
- HO-1调制是一种潜在的治疗策略,可以减轻白细胞在TV中的招募.
- 针对CD62E提供了一种有前途的方法来预防电视和内增生.
- 这些发现表明新的治疗途径,以防止移植排斥和器官衰竭.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K


